JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHWARTZ, J.-C.
Right arrow Articles by CAILLENS, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHWARTZ, J.-C.
Right arrow Articles by CAILLENS, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-HISTIDINE
*HISTAMINE
*METHYLDOPA
*TRANYLCYPROMINE
*TRITIUM
Journal of Pharmacology And Experimental Therapeutics, Vol. 184, Issue 3, 766-779, 1973
Copyright © 1973 by American Society for Pharmacology and Experimental Therapeutics


METABOLISM OF METHYLHISTAMINE FORMED THROUGH A NEW PATHWAY: DECARBOXYLATION OF L-3-METHYLHISTIDINE

JEAN-CHARLES SCHWARTZ 1, CHRISTIANE ROSE 1, and HENRI CAILLENS 1

1 Unité de Neurobiologie de l’I.N.S.E.R.M Höpital Sainte-Anne, Paris, France

Biosynthesis of methylhistamine (MHA) may occur in part by a pathway which does not involve histamine (HA) transmethylation: 3H-MHA was isolated by ion-exchange chromatography followed by solvent extraction and identified by thin-layer chromatography from several tissue extracts of mice previously injected with tracer doses of the natural amino acid 3H-l-3-methylhistidine (MeHis). Tissues, such as the stomach, which synthesized 3H-MHA at the highest rate were also capable of highest decarboxylation of 3H-histidine (3H-His). 3H-MHA formation in the stomach of 3H-MeHis-injected mice was markedly reduced after pretreatment with nonradioactive l-His (500 mg/kg) or with the histidine decarboxylase inhibitor, brocresine (200 mg/kg). Experiments with rat stomach supernatant confirmed that the specific His decarboxylase was probably responsible for MeHis decarboxylation: 3H-MHA formation was not affected by 10-4 M agr-methyldopa but was inhibited by 10-4 M brocresine and was highly reduced in extracts from food-deprived rats. Moreover, 3H-His and 3H-MeHis were found to compete mutually for this enzyme, but the affinity of MeHis (Km = 9 x 10-3 M) was lower than that of His (Km = 3 x 10-4 M). 3H-MHA synthesized from 3H-MeHis was released by treatments known to induce endogenous HA release: this was the case for these aminmes from mouse stomach after food intake or vagal stimulation induced by insulin as well as from rat peritonmeal mast cells after in vitro addition of compound 48/80. MeHis loading (1000 mg/kg) in mice resulted in significant reductions in 3H-HA formatiom in the stomach and in endogenous HA levels in brain. Since MeHis is known to be normally present in plasma and tissues, our results indicate that HA and MHA are synthesized and stored in the same sites from which they may be released together under physiological or pathological conditions.

Submitted on August 3, 1972
Accepted on October 13, 1972




This article has been cited by other articles:


Home page
ScienceHome page
M. Garbarg, G. Barbin, J. Feger, and J.-C. Schwartz
Histaminergic Pathway in Rat Brain Evidenced by Lesions of the Medial Forebrain Bundle
Science, November 29, 1974; 186(4166): 833 - 835.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics.